|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000109685 |
Summary for WHSC1 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000109685 | Gene symbol | WHSC1 |
| Gene name | nuclear receptor binding SET domain protein 2 | |
| HGNC | 12766 | |
| Entrez ID | 7468 | |
| Gene type | protein_coding | |
| Synonyms | NSD2|MMSET|KMT3G | |
| UniProtAcc | O96028 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for WHSC1 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| WHSC1 | 2.15e+03 | 1.52e+00 | 3.32e-01 | 4.60e+00 | 4.28e-06 | 2.66e-05 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for WHSC1 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for WHSC1 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for WHSC1 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Landscape of exon skipping events across multiple cancer types. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for WHSC1 |
| ∗Please access CAeditome for RNA editing annotation. |
Landscape of RNA editing events across multiple cancer types. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| STAD | WHSC1-014 | chr4_1888305_+ | 3.18e-01 | 2.14e-01 | 2.13e+00 | 3.30e-02 | 4.96e-02 | 1.04e-01 |
| STAD | WHSC1-010 | chr4_1911513_+ | 4.51e-01 | 3.59e-01 | 1.96e+00 | 4.95e-02 | 4.99e-02 | 9.20e-02 |
| LAML | WHSC1-010 | chr4_1886644_+ | 7.49e-01 | 8.73e-01 | -2.23e+00 | 2.60e-02 | 4.94e-02 | -1.24e-01 |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for WHSC1 |
TFs related to WHSC1.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| PAAD | ALX3 | WHSC1 | 4.20e+00 | 9.82e-01 | 3.29e+00 | 6.62e-03 | Male-biased |
| PAAD | LHX8 | WHSC1 | 4.69e+00 | 9.80e-01 | 3.93e+00 | 1.44e-02 | Male-biased |
| PAAD | MIXL1 | WHSC1 | 4.18e+00 | 9.81e-01 | 3.29e+00 | 7.55e-03 | Male-biased |
| PAAD | PROP1 | WHSC1 | 4.22e+00 | 9.84e-01 | 3.27e+00 | 5.44e-03 | Male-biased |
| PCPG | ZNF418 | WHSC1 | 3.90e+00 | 9.81e-01 | 2.67e+00 | 1.31e-03 | Male-biased |
| SKCM | ZNF418 | WHSC1 | 2.71e+00 | 4.85e-04 | 4.60e+00 | 9.88e-01 | Female-biased |
WHSC1 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for WHSC1 |
RBPs related to ES in WHSC1.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | SRSF1 | exon_skip_421426 | 8.93e+00 | 9.82e-01 | 8.61e+00 | 1.35e-02 | Male-biased |
| THYM | EIF4B | exon_skip_421436 | 7.46e+00 | 7.52e-03 | 7.80e+00 | 9.83e-01 | Female-biased |
| THYM | ESRP2 | exon_skip_421445 | 8.28e+00 | 5.44e-03 | 8.65e+00 | 9.89e-01 | Female-biased |
| LUSC | SART3 | exon_skip_421411 | 6.98e+00 | 9.80e-01 | 6.55e+00 | 5.64e-03 | Male-biased |
| PAAD | FMR1 | exon_skip_421409 | 8.24e+00 | 1.28e-02 | 8.52e+00 | 9.81e-01 | Female-biased |
WHSC1 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs75654334 | chr4:1173862:C:T | - | 0.145680829115465 | 0.0491005155401764 | PAAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs13136672 | chr4:2354975:T:C | - | 0.183824271870948 | 3.3805597623766e-05 | SARC | Male-baised eQTL |
| rs4974651 | chr4:2355962:C:A | - | 0.180974717558106 | 9.97099510241366e-05 | SARC | Male-baised eQTL |
| rs4974676 | chr4:2357995:G:A | - | 0.180974717558106 | 9.97099510241366e-05 | SARC | Male-baised eQTL |
| rs4974677 | chr4:2358072:T:C | - | 0.180974717558106 | 9.97099510241366e-05 | SARC | Male-baised eQTL |
| rs11726484 | chr4:2359492:T:C | - | 0.180974717558106 | 9.97099510241366e-05 | SARC | Male-baised eQTL |
| rs11737085 | chr4:2359556:G:A | - | 0.180974717558106 | 9.97099510241366e-05 | SARC | Male-baised eQTL |
| rs4974678 | chr4:2361422:G:A | - | 0.180974717558106 | 9.97099510241366e-05 | SARC | Male-baised eQTL |
| rs4974679 | chr4:2364233:G:C | - | 0.180974717558106 | 9.97099510241366e-05 | SARC | Male-baised eQTL |
| rs34319356 | chr4:2434254:G:A | - | 0.121010135721666 | 0.0139964836042809 | SARC | Male-baised eQTL |
| rs71606394 | chr4:2430108:A:G | - | 0.117472380443072 | 0.0196876639607888 | SARC | Male-baised eQTL |
| rs57650930 | chr4:2430674:G:A | - | 0.117472380443072 | 0.0196876639607888 | SARC | Male-baised eQTL |
| rs57815860 | chr4:2430697:C:T | - | 0.117472380443072 | 0.0196876639607888 | SARC | Male-baised eQTL |
| rs55835040 | chr4:2419841:T:C | - | 0.113216095108031 | 0.0251503065037322 | SARC | Male-baised eQTL |
| rs11721696 | chr4:2420184:T:A | - | 0.113216095108031 | 0.0251503065037322 | SARC | Male-baised eQTL |
| rs67762343 | chr4:2377616:G:A | - | 0.157049746097309 | 0.0370220322919335 | SARC | Male-baised eQTL |
| rs34023324 | chr4:2372996:C:T | - | 0.153096676380324 | 0.0384604286688515 | SARC | Male-baised eQTL |
| rs55982444 | chr4:2377222:C:T | - | 0.153096676380324 | 0.0384604286688515 | SARC | Male-baised eQTL |
| rs2279180 | chr4:889251:A:G | - | 0.0466420508988097 | 0.00462744181195971 | LUSC | Male-baised eQTL |
| rs115260110 | chr4:889540:T:A | - | 0.0466420508988097 | 0.00462744181195971 | LUSC | Male-baised eQTL |
| rs115830981 | chr4:889541:C:A | - | 0.0466420508988097 | 0.00462744181195971 | LUSC | Male-baised eQTL |
| rs79692917 | chr4:891442:T:C | - | 0.0466420508988097 | 0.00462744181195971 | LUSC | Male-baised eQTL |
| rs11725376 | chr4:894211:C:G | - | 0.0466420508988097 | 0.00462744181195971 | LUSC | Male-baised eQTL |
| rs75713448 | chr4:894357:C:T | - | 0.0466420508988097 | 0.00462744181195971 | LUSC | Male-baised eQTL |
| rs75214905 | chr4:887447:A:G | - | 0.0466440613987938 | 0.00463716941378464 | LUSC | Male-baised eQTL |
| rs11731840 | chr4:883018:G:A | - | 0.0439257548445352 | 0.0130736183051039 | LUSC | Male-baised eQTL |
| rs80255154 | chr4:874001:A:T | - | 0.0443284137418727 | 0.0143234510728681 | LUSC | Male-baised eQTL |
| rs78509255 | chr4:874002:T:A | - | 0.0443284137418727 | 0.0143234510728681 | LUSC | Male-baised eQTL |
| rs73064427 | chr4:881599:A:G | - | 0.0408363183224208 | 0.0255316075594508 | LUSC | Male-baised eQTL |
| rs10902760 | chr4:882353:G:C | - | 0.0400451583404587 | 0.0298869208994788 | LUSC | Male-baised eQTL |
| rs3736086 | chr4:882611:T:C | - | 0.0400451583404587 | 0.0298869208994788 | LUSC | Male-baised eQTL |
| rs62297670 | chr4:5772729:A:C | - | 0.0923954294811494 | 0.0121675571862433 | BLCA | Male-baised eQTL |
| rs3856955 | chr4:5773141:G:A | - | 0.0906531289652851 | 0.043003681760083 | BLCA | Male-baised eQTL |
| rs76047495 | chr4:4881399:G:C | - | 0.0729403622082225 | 0.0473515405321367 | BLCA | Male-baised eQTL |
| rs371781143 | chr4:6117522:C:T | - | 0.131045046884195 | 0.00895885939270861 | LUAD | Male-baised eQTL |
| rs112927915 | chr4:6117335:A:T | - | 0.128545579030007 | 0.010160745996552 | LUAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg10778379 | chr4:1900738 | gene,exon,CDS | -0.378374290830178 | 3.11767257979819e-05 | -0.44731329467602976 | 4.2539479440570925e-08 | THCA |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg13112524 | chr4:1981375 | gene,exon,UTR | -0.380594520451856 | 8.6805316237794e-06 | -0.6093413350932411 | 1.0596917500818185e-08 | KIRP |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of WHSC1 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |